Vortex Formation Time in Patients with Hypertrophic Cardiomyopathy
Maragiannis, D, Schutt, R, Alvarez, P, Chin, K, Buergler, J, Little, S, Shah, D & Nagueh, S 2015, AHA-Scientific Sessions, Orlando, United States, 11/7/15, .
Early post-operative dysfunction of a mechanical aortic valve.
Shah, T, Ramlawi, B, Buergler, J, Chang, S & Little, SH 2012, Houston Methodist DeBakey Cardiovascular Journal, vol 8, no. 2, pp. 54-55.
Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: A multicenter north american registry
Nagueh, SF, Groves, BM, Schwartz, L, Smith, KM, Wang, A, Bach, RG, Nielsen, C, Leya, F, Buergler, JM, Rowe, SK, Woo, A, Maldonado, YM & Spencer, WH 2011, Journal of the American College of Cardiology, vol 58, no. 22, pp. 2322-2328. DOI:
Impact of computerized dosing on eptifibatide-associated bleeding and mortality
Putney, DR, Kleiman, NS, Fromm, RE & Buergler, JM 2009, American Heart Journal, vol 158, no. 6, pp. 1018-1023. DOI:
Delayed Untwisting. The Mechanistic Link Between Dynamic Obstruction and Exercise Tolerance in Patients With Hypertrophic Obstructive Cardiomyopathy
Wang, J, Buergler, JM, Veerasamy, K, Ashton, YP & Nagueh, SF 2009, Journal of the American College of Cardiology, vol 54, no. 14, pp. 1326-1334. DOI:
Initial experience with alcohol septal ablation using a novel magnetic navigation system
Buergler, JM, Alam, S, Spencer, W, Kleiman, NS, Melendez, Y, Franklin, J & Nagueh, SF 2007, Journal of Interventional Cardiology, vol 20, no. 6, pp. 559-563. DOI:
Outcome of Surgical Myectomy After Unsuccessful Alcohol Septal Ablation for the Treatment of Patients With Hypertrophic Obstructive Cardiomyopathy
, Buergler, JM
, Quinones, MA, Spencer, WH & Lawrie, GM 2007, Journal of the American College of Cardiology, vol 50, no. 8, pp. 795-798. DOI:
Endovascular occlusion of right to left arteriovenous shunt associated with persistent left superior vena cava
Kougias, P, Peden, EK, Lin, P, Buergler, J & Lumsden, AB 2006, Journal of Vascular Surgery, vol 44, no. 4, pp. 875-878. DOI:
Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease
Nambi, V, Buergler, JM, Lakkis, NM, Franklin, J, Spencer, WH & Nagueh, SF 2005, American Journal of Cardiology, vol 96, no. 4, pp. 580-581. DOI:
Effects of SolCD39, a novel inhibitor of platelet aggregation, on platelet deposition and aggregation after PTCA in a porcine model
Buergler, JM, Maliszewski, CR, Broekman, MJ, Kaluza, GL, Schulz, DG, Marcus, AJ, Raizner, AE, Kleiman, NS & Ali, NM 2005, Journal of Thrombosis and Thrombolysis, vol 19, no. 2, pp. 115-122. DOI:
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: The XaNADU-PCI pilot
Alexander, JH, Dyke, CK, Yang, H, Becker, RC, Hasselblad, V, Zillman, LA, Kleiman, NS, Hochman, JS, Berger, PB, Cohen, EA, Lincoff, AM, Saint-Jacques, H, Chetcuti, S, Burton, JR, Buergler, JM, Spence, FP, Shimoto, Y, Robertson, TL, Kunitada, S, Bovill, EG, Armstrong, PW & Harrington, RA 2004, Journal of Thrombosis and Haemostasis, vol 2, no. 2, pp. 234-241. DOI:
Apicoaortic conduit in a patient with severe hemolysis after three aortic valve replacements
Skrabal, CA, Loebe, M, Thompson, LO, Buergler, JM, Youker, KA, Lafuente, JA & Noon, GP 2004, Journal of Thoracic and Cardiovascular Surgery, vol 127, no. 1, pp. 270-272. DOI:
Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide
Kleiman, NS, Klem, J, Fernandes, LS, Rubin, H, Challa, S, Solomon, S, Maresh, K, Arora, U, Klem, E, Buergler, J, Mathew, S, Browning, A & DeLao, T 2002, American Heart Journal, vol 143, no. 4, pp. 585-593. DOI:
Long-term effects of intracoronary ß-radiation in balloon- and stent-injured porcine coronary arteries
Kaluza, GL, Raizner, AE, Mazur, W, Schulz, DG, Buergler, JM, Fajardo, LF, Tio, FO & Ali, NM 2001, Circulation, vol 103, no. 16, pp. 2108-2113.